首页> 外文期刊>Oncology reports >MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A
【24h】

MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A

机译:通过靶向CDC25A,MiR-449a在子宫内膜癌中起抑癌作用

获取原文
获取原文并翻译 | 示例
       

摘要

Accumulating evidence has demonstrated that microRNAs (miRNAs) play critical roles in cancer initiation and development by functioning either as oncogenes or as tumor suppressors. The role of microRNA-449a (miR-449a) in endometrial cancer remains unclear. We examined the levels of miR-449a and miR-449b in benign endometrium, type I and type II endometrial cancer tissues by quantitative real-time polymerase chain reaction. To further investigate the roles of miR-449a in regulating the behavior of endometrial cancer cells, we overexpressed miR-449a in the endometrial cancer cell line HEC-1B, which had low endogenous miR-449a expression. We analyzed the effects of miR-449a overexpression on CDC25 expression, proliferation, invasion and apoptosis of HEC-1B cells. We found that miR-449a and miR-449b levels were markedly reduced in type II endometrial cancer tissues but not in type I endometrial cancer tissues compared with normal endometrium. Overexpression of miR-449a significantly inhibited the proliferation, invasion and clonogenic survival of HEC-1B cells. MiR-449a overexpression also induced apoptosis in HEC-1B cells. In addition, real-time RT-PCR and western blot analysis showed that CDC25A expression was suppressed by miR-449a overexpression. Our results suggest that miR-449a may act as a tumor suppressor by targeting CDC25A in endometrial cancer.
机译:越来越多的证据表明,微小RNA(miRNA)作为癌基因或抑癌基因,在癌症的发生和发展中起着至关重要的作用。 microRNA-449a(miR-449a)在子宫内膜癌中的作用尚不清楚。我们通过定量实时聚合酶链反应检查了良性子宫内膜,I型和II型子宫内膜癌组织中miR-449a和miR-449b的水平。为了进一步研究miR-449a在调节子宫内膜癌细胞行为中的作用,我们在低内源性miR-449a表达的子宫内膜癌细胞系HEC-1B中过表达miR-449a。我们分析了miR-449a过表达对HEC-1B细胞CDC25表达,增殖,侵袭和凋亡的影响。我们发现,与正常子宫内膜相比,II型子宫内膜癌组织中的miR-449a和miR-449b水平显着降低,而I型子宫内膜癌组织中却没有。 miR-449a的过表达显着抑制了HEC-1B细胞的增殖,侵袭和克隆形成存活。 MiR-449a过表达也诱导了HEC-1B细胞凋亡。另外,实时RT-PCR和蛋白质印迹分析表明,miR-449a过表达抑制了CDC25A的表达。我们的结果表明,miR-449a可通过靶向子宫内膜癌中的CDC25A来充当肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号